Market News

    RSS Feed

Homology Medicines Inc. Launches as a Newly-Formed Genetic Medicines Company Founded Upon a Unique City of Hope Gene Editing and Gene Transfer Platform Technology

May 2, 2016 | DUARTE, Calif.–(BUSINESS WIRE)–City of Hope today announced that it has licensed its pioneering
AAV-based gene editing technology exclusively to Homology Medicines
Inc., a newly-formed genetic medicines company. A City of Hope lab led
by Saswati Chatterjee, Ph.D., developed the single platform technology
that enables both gene editing and gene therapy with a built-in in
vivo  … Read More

Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A) as a Valuable Tool in Identifying Viable Embryos During In Vitro Fertilization (IVF)

April 12, 2016 | Fertility and Sterility Published Research Yields Insight on Detection of Mosaicism Aiding in Embryo Selection, Resulting in Higher Implantation Rates and Lower Rates of Miscarriage

LIVINGSTON, NJ–(Marketwired – Apr 12, 2016) – Reprogenetics, the largest genetics laboratory in the United States specializing in Preimplantation Genetic Diagnosis (PGD), has published a clinical  … Read More

Orthopaedic Institute for Children’s Research May Lead to Treatments for Patients with Rare Bone Disorders

April 4, 2016 | Breakthrough research being funded by the Orthopaedic Institute for Children (OIC) is creating new hope for children afflicted with a rare genetic disorder that turns muscle, tendons and ligaments into bone, thus constraining movement and ultimately leading to loss of mobility. For those afflicted with this deadly disease, fibrodysplasia ossificans  … Read More